TransMedics names new CFO and reiterates 2026 revenue guidance

Go back to TransMedics names new CFO and reiterates 2026 revenue guidance
(NASDAQ: TMDX) Delayed: 87.29 +0.87 (1.01%)
Previous Close $86.42    52 Week High
Open $87.35    52 Week Low
Day High $89.53    P/E N/A 
Day Low $86.75    EPS
Volume 590,891